The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is sponsoring a study here at Northwestern Medicine to optimize medication management for women who take antidepressants during pregnancy.
Why is this research important?
Depression in pregnancy affects one in seven mothers and causes suffering to mothers and risks to the healthy development of their children. How to treat women optimally during pregnancy will be determined by this research.
Many women take antidepressants during pregnancy to help manage their mood symptoms, but additional information is needed to help providers optimize treatment.
Your participation in this study may lead to knowledge that can help improve SSRI treatment for other mothers in the future. Our expert team will also communicate with your current prescriber to provide additional monitoring during this important time.
You may be eligible to participate if you:
- Are 18 years of age or older
- Are currently at or less than 18 weeks pregnant
- Speak English or Spanish
- Taking sertraline (Zoloft), fluoxetine (Prozac), citalopram (Celexa), or escitalopram (Lexapro)
- Monthly blood draws for drug levels
- Monthly assessments of your mood and medication side effects
- $30 for each completed study visit
- Free on-site parking or up to $20 for travel expenses
If you are interested in participating or would like to hear more information, please contact our research team at firstname.lastname@example.org or 1-855-99-ASHER.